Closing Bell: Nervgen Pharma Corp down on Wednesday (NGEN)

In today's trading, Nervgen Pharma Corp stock opened at $3.00 and closed at $2.92. It traded at a low of $2.92 to a high of $3.05.

Shares eased -2.01% from the previous day's close of $2.98.

Today across North America, the TSX Composite closed 1.07% at 22995.39, the S&P 500 closed 0.64% at 5667.20, the Dow Jones Industrial Average closed 1.85% at 40954.48 and the Nasdaq Composite closed 0.20% at 18509.34.

Nervgen Pharma Corp traded under NGEN on the Toronto Venture Exchange (TSX-V).

Trading volume was 37,707 on 95 total trades, while having an average volume of 54,182 over 5 days.

The TSX-V overall saw 2,100 price advancers against 3,108 declines and 117 unchanged.

During the prior 52 weeks, NGEN.VN has traded as high as $3.98 (February 05,2024) and low as $1.58 (December 14,2023). Moreover, the shares have soared 68.79% in 52 weeks, while in 2024, they have gained 8.15%.

Following today's trading, Nervgen Pharma Corp has a market capitalization of $208.38 million on a float of 69,928 shares outstanding. Its annual EPS is $-0.34.

Nervgen Pharma Corp is a TSX Biotechnology company headquartered in Vancouver, CAN.

Nervgen Pharma Corp is holding an average recommendation of "Strong Sell" from 0.00 analysts according to Zacks. From those 0 analysts,.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..